Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.81B |
| Enterprise value | 2.44B |
| Trailing P/E | 478.56 |
| Forward P/E | 111.11 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.92 |
| Price/book (mrq) | 7.72 |
| Enterprise value/revenue | 9.54 |
| Enterprise value/EBITDA | -15.18 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.99 |
| 52-week change 3 | -23.03% |
| S&P500 52-week change 3 | 13.11% |
| 52-week high 3 | 42.48 |
| 52-week low 3 | 23.09 |
| 50-day moving average 3 | 29.63 |
| 200-day moving average 3 | 32.40 |
Share statistics
| Avg vol (3-month) 3 | 900.55k |
| Avg vol (10-day) 3 | 791.07k |
| Shares outstanding 5 | 107.19M |
| Implied shares outstanding 6 | 107.19M |
| Float 8 | 103.94M |
| % held by insiders 1 | 4.96% |
| % held by institutions 1 | 70.74% |
| Shares short (14 Sept 2023) 4 | 6.1M |
| Short ratio (14 Sept 2023) 4 | 6.81 |
| Short % of float (14 Sept 2023) 4 | 6.78% |
| Short % of shares outstanding (14 Sept 2023) 4 | 5.69% |
| Shares short (prior month 14 Aug 2023) 4 | 6.06M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 16 Nov 2011 |
Financial highlights
Fiscal year
| Fiscal year ends | 29 Sept 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | -70.69% |
| Operating margin (ttm) | -70.45% |
Management effectiveness
| Return on assets (ttm) | -14.58% |
| Return on equity (ttm) | -43.03% |
Income statement
| Revenue (ttm) | 256.21M |
| Revenue per share (ttm) | 2.41 |
| Quarterly revenue growth (yoy) | -51.20% |
| Gross profit (ttm) | 243.23M |
| EBITDA | -169.21M |
| Net income avi to common (ttm) | -181.11M |
| Diluted EPS (ttm) | -1.70 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 451.7M |
| Total cash per share (mrq) | 4.21 |
| Total debt (mrq) | 345.8M |
| Total debt/equity (mrq) | 90.53% |
| Current ratio (mrq) | 6.70 |
| Book value per share (mrq) | 3.41 |
Cash flow statement
| Operating cash flow (ttm) | -197.37M |
| Levered free cash flow (ttm) | -226.58M |
© 2023 Yahoo. All rights reserved.
